Bio-One Signs Agreement To Acquire $17 Million Revenue China Company.

Business Editors/Health/Medical Writers

ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 24, 2004

Bio-One Corporation (OTCBB:BICO) ("Bio-One" or the "Company"). Bio-One Corporation has agreed to acquire a 51% interest in a leading manufacturer and distributor of glucose in China, which possesses a 30% market share. The Chinese business, which holds three patents, has reported 2003 revenues of $17 million, EBITDA of 22% and has assets of $17 million. Purchase terms include cash and Convertible Preferred stock at $2.00 per share, with lock-up terms regarding sale. The 450-employee business will continue to be run with its present management team. The People's Republic of China Joint Venture documents have been signed and the closing is anticipated to occur upon the completion of the certified audits at the end of this March.

Bio-One President and CEO Armand Dauplaise stated, "Frank Clark, our Chairman of the Board and I have just returned from a lengthy and very successful trip to the People's Republic of China. This trip was the culmination of a great deal of hard work from our advance team led by Mary Xia and Roy Lerman, a Bio-One Board member, over a period of several months. We believe this acquisition to be one of several opportunities that exist for Bio-One to establish a presence in China."

Bio-One is aggressively pursuing additional candidates in China as well as North America that meet the Company's criteria for profitability and revenue growth. Further substantive announcements are anticipated to follow shortly.

Business Summary

Bio-One Corporation was formed to serve the emerging niche of preventive and alternative healthcare through nutritional supplements. This niche has grown to a multi-billion dollar industry. The market is considered global. The Company's strategy is to build its business through vertical integration of manufacturing, distribution and marketing by selectively acquiring industry leaders in each distribution channel. Bio-One intends to be one of the first to launch its plan by targeting companies under $25 million in annual sales. The Company's home state, Florida, ranks first nationally in per capita consumption of nutritional supplements and second only to California in total industry sales. Bio-One's goals are threefold; 1) to serve people worldwide who desire vitality and longevity; 2) to interface a quality and value growth philosophy through the acquisition of selected businesses; 3) to provide a superior return on investment for Company shareholders.

Bio-One Corporation is committed to its mission of the continuing pursuit of excellence in serving our customers, our suppliers, our team members and our shareholders. Bio-One intends to accomplish its mission and goals through the application of its management philosophy, which is to treat others the way they would want to be treated.

Certain statements released by Bio-One Corporation that are forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Editors and investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the Company's business prospects and performance. These include, but are not limited to, economic, competitive, governmental, technological and other risks detailed in the company's registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.